Acrotech Biopharma patents expiration

1. Khapzory patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11541012 ACROTECH BIOPHARMA Compositions comprising disodium levofolinate
Mar, 2039

(15 years from now)

Drugs and Companies using LEVOLEUCOVORIN ingredient

Market Authorisation Date: 19 October, 2018

Treatment: NA


More Information on Dosage

KHAPZORY family patents

Family Patents